497 related articles for article (PubMed ID: 30696113)
1. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
Nack A; Brendel M; Nedelcu J; Daerr M; Nyamoya S; Beyer C; Focke C; Deussing M; Hoornaert C; Ponsaerts P; Schmitz C; Bartenstein P; Rominger A; Kipp M
Cells; 2019 Jan; 8(2):. PubMed ID: 30696113
[TBL] [Abstract][Full Text] [Related]
2. Molecular Imaging of Immune Cell Dynamics During De- and Remyelination in the Cuprizone Model of Multiple Sclerosis by [
Zinnhardt B; Belloy M; Fricke IB; Orije J; Guglielmetti C; Hermann S; Wagner S; Schäfers M; Van der Linden A; Jacobs AH
Theranostics; 2019; 9(6):1523-1537. PubMed ID: 31037121
[No Abstract] [Full Text] [Related]
3. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of [¹²³I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation.
Mattner F; Bandin DL; Staykova M; Berghofer P; Gregoire MC; Ballantyne P; Quinlivan M; Fordham S; Pham T; Willenborg DO; Katsifis A
Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1516-28. PubMed ID: 21484375
[TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO
Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338
[TBL] [Abstract][Full Text] [Related]
6. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
[TBL] [Abstract][Full Text] [Related]
7. In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis.
Airas L; Dickens AM; Elo P; Marjamäki P; Johansson J; Eskola O; Jones PA; Trigg W; Solin O; Haaparanta-Solin M; Anthony DC; Rinne J
J Nucl Med; 2015 Feb; 56(2):305-10. PubMed ID: 25572093
[TBL] [Abstract][Full Text] [Related]
8.
Belloli S; Zanotti L; Murtaj V; Mazzon C; Di Grigoli G; Monterisi C; Masiello V; Iaccarino L; Cappelli A; Poliani PL; Politi LS; Moresco RM
J Neuroinflammation; 2018 Feb; 15(1):33. PubMed ID: 29402285
[TBL] [Abstract][Full Text] [Related]
9. Laquinimod ameliorates secondary brain inflammation.
Nedelcu J; Reinbach C; Riedler P; Brendel M; Rominger A; Kaye J; Behrangi N; Jiangshan Z; Schmitz C; Kipp M
Neurobiol Dis; 2020 Feb; 134():104675. PubMed ID: 31731041
[TBL] [Abstract][Full Text] [Related]
10. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization.
Chen MK; Baidoo K; Verina T; Guilarte TR
Brain; 2004 Jun; 127(Pt 6):1379-92. PubMed ID: 15069023
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.
Mattner F; Staykova M; Berghofer P; Wong HJ; Fordham S; Callaghan P; Jackson T; Pham T; Gregoire MC; Zahra D; Rahardjo G; Linares D; Katsifis A
J Nucl Med; 2013 Feb; 54(2):291-8. PubMed ID: 23321458
[TBL] [Abstract][Full Text] [Related]
12. PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.
de Paula Faria D; de Vries EF; Sijbesma JW; Dierckx RA; Buchpiguel CA; Copray S
Neuroimage; 2014 Feb; 87():395-402. PubMed ID: 24188813
[TBL] [Abstract][Full Text] [Related]
13. Changes in neurosteroidogenesis during demyelination and remyelination in cuprizone-treated mice.
Leicaj ML; Pasquini LA; Lima A; Gonzalez Deniselle MC; Pasquini JM; De Nicola AF; Garay LI
J Neuroendocrinol; 2018 Nov; 30(11):e12649. PubMed ID: 30303567
[TBL] [Abstract][Full Text] [Related]
14. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
Leva G; Klein C; Benyounes J; Hallé F; Bihel F; Collongues N; De Seze J; Mensah-Nyagan AG; Patte-Mensah C
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3016-3027. PubMed ID: 28899788
[TBL] [Abstract][Full Text] [Related]
15. Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein.
Fan Z; Calsolaro V; Atkinson RA; Femminella GD; Waldman A; Buckley C; Trigg W; Brooks DJ; Hinz R; Edison P
J Nucl Med; 2016 Nov; 57(11):1753-1759. PubMed ID: 27261523
[TBL] [Abstract][Full Text] [Related]
16. Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.
Höflich KM; Beyer C; Clarner T; Schmitz C; Nyamoya S; Kipp M; Hochstrasser T
Brain Res; 2016 Nov; 1650():125-133. PubMed ID: 27592741
[TBL] [Abstract][Full Text] [Related]
17. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
[TBL] [Abstract][Full Text] [Related]
18. Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.
Behrangi N; Heinig L; Frintrop L; Santrau E; Kurth J; Krause B; Atanasova D; Clarner T; Fragoulis A; Joksch M; Rudolf H; Meuth SG; Joost S; Kipp M
Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2204509119. PubMed ID: 36161894
[TBL] [Abstract][Full Text] [Related]
19. TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis.
Völk S; Unterrainer M; Albert NL; Havla J; Gerdes LA; Schumacher M; Brendel M; Kaiser L; Adorjan K; Rupprecht R; Bartenstein P; Kümpfel T; Danek A
Clin Nucl Med; 2020 Oct; 45(10):e447-e448. PubMed ID: 32796248
[TBL] [Abstract][Full Text] [Related]
20. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
